Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 622K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Mansukhani, A. Articles by Basilico, C. Search for Related Content PubMed PubMed Citation Articles by Mansukhani, A. Articles by Basilico, C. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/2000//1297 $5.00
The Journal of Cell Biology, Volume 149, Number 6, , 2000 1297-1308

Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts

^a Department of Microbiology, New York University School of Medicine, New York, New York 10016
Department of Microbiology, 550 First Ave., New York University School of Medicine, New York, NY 10016.(212) 263-8714(212) 263-5341

basilc01{at}med.nyu.edu

Fibroblast growth factors (FGF) play a critical role in bone growth and development affecting both chondrogenesis and osteogenesis. During the process of intramembranous ossification, which leads to the formation of the flat bones of the skull, unregulated FGF signaling can produce premature suture closure or craniosynostosis and other craniofacial deformities. Indeed, many human craniosynostosis disorders have been linked to activating mutations in FGF receptors (FGFR) 1 and 2, but the precise effects of FGF on the proliferation, maturation and differentiation of the target osteoblastic cells are still unclear. In this report, we studied the effects of FGF treatment on primary murine calvarial osteoblast, and on OB1, a newly established osteoblastic cell line. We show that FGF signaling has a dual effect on osteoblast proliferation and differentiation. FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase. However, immature osteoblasts respond to FGF treatment with increased proliferation, whereas in differentiating cells FGF does not induce DNA synthesis but causes apoptosis. When either primary or OB1 osteoblasts are induced to differentiate, FGF signaling inhibits expression of alkaline phosphatase, and blocks mineralization. To study the effect of craniosynostosis-linked mutations in osteoblasts, we introduced FGFR2 carrying either the C342Y (Crouzon syndrome) or the S252W (Apert syndrome) mutation in OB1 cells. Both mutations inhibited differentiation, while dramatically inducing apoptosis. Furthermore, we could also show that overexpression of FGF2 in transgenic mice leads to increased apoptosis in their calvaria. These data provide the first biochemical analysis of FGF signaling in osteoblasts, and show that FGF can act as a cell death inducer with distinct effects in proliferating and differentiating osteoblasts.

Key Words: craniosynostosis • apoptosis • fibroblast growth factors • fibroblast growth factor receptors • osteoblast

© 2000 The Rockefeller University Press

Abbreviations used in this paper: ALP, alkaline phosphatase; BrdU, bromodeoxyuridine; FGFR, fibroblast growth factor receptors; OC, osteocalcin.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Miraoui, H., Oudina, K., Petite, H., Tanimoto, Y., Moriyama, K., Marie, P. J. (2009). Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling. J. Biol. Chem. 284: 4897-4904 [Abstract] [Full Text]  
• Sun, F., Xie, Q., Ma, J., Yang, S., Chen, Q., Hong, A. (2009). Nuclear Factor Y Is Required for Basal Activation and Chromatin Accessibility of Fibroblast Growth Factor Receptor 2 Promoter in Osteoblast-like Cells. J. Biol. Chem. 284: 3136-3147 [Abstract] [Full Text]  
• Rawlins, J. T., Fernandez, C. R., Cozby, M. E., Opperman, L. A. (2008). Timing of Egf Treatment Differentially Affects Tgf-{beta}2 Induced Cranial Suture Closure. Exp Biol Med 233: 1518-1526 [Abstract] [Full Text]  
• Ambrosetti, D., Holmes, G., Mansukhani, A., Basilico, C. (2008). Fibroblast Growth Factor Signaling Uses Multiple Mechanisms To Inhibit Wnt-Induced Transcription in Osteoblasts. Mol. Cell. Biol. 28: 4759-4771 [Abstract] [Full Text]  
• Dutt, A., Salvesen, H. B., Chen, T.-H., Ramos, A. H., Onofrio, R. C., Hatton, C., Nicoletti, R., Winckler, W., Grewal, R., Hanna, M., Wyhs, N., Ziaugra, L., Richter, D. J., Trovik, J., Engelsen, I. B., Stefansson, I. M., Fennell, T., Cibulskis, K., Zody, M. C., Akslen, L. A., Gabriel, S., Wong, K.-K., Sellers, W. R., Meyerson, M., Greulich, H. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc. Natl. Acad. Sci. USA 105: 8713-8717 [Abstract] [Full Text]  
• Li, S., Quarto, N., Longaker, M. T. (2007). Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts. Am. J. Physiol. Cell Physiol. 293: C1834-C1842 [Abstract] [Full Text]  
• Com, E., Lagadec, C., Page, A., El Yazidi-Belkoura, I., Slomianny, C., Spencer, A., Hammache, D., Rudkin, B. B., Hondermarck, H. (2007). Nerve Growth Factor Receptor TrkA Signaling in Breast Cancer Cells Involves Ku70 to Prevent Apoptosis. Mol. Cell. Proteomics 6: 1842-1854 [Abstract] [Full Text]  
• Bouvard, D., Aszodi, A., Kostka, G., Block, M. R., Albiges-Rizo, C., Fassler, R. (2007). Defective osteoblast function in ICAP-1-deficient mice. Development 134: 2615-2625 [Abstract] [Full Text]  
• Maric, D., Fiorio Pla, A., Chang, Y. H., Barker, J. L. (2007). Self-Renewing and Differentiating Properties of Cortical Neural Stem Cells Are Selectively Regulated by Basic Fibroblast Growth Factor (FGF) Signaling via Specific FGF Receptors. J. Neurosci. 27: 1836-1852 [Abstract] [Full Text]  
• Eid, K., Labler, L., Ertel, W., Trentz, O., Keel, M. (2006). Systemic effects of severe trauma on the function and apoptosis of human skeletal cells. J Bone Joint Surg Br 88-B: 1394-1400 [Abstract] [Full Text]  
• Hatch, N. E., Hudson, M., Seto, M. L., Cunningham, M. L., Bothwell, M. (2006). Intracellular Retention, Degradation, and Signaling of Glycosylation-deficient FGFR2 and Craniosynostosis Syndrome-associated FGFR2C278F. J. Biol. Chem. 281: 27292-27305 [Abstract] [Full Text]  
• Wang, Y., Xiao, R., Yang, F., Karim, B. O., Iacovelli, A. J., Cai, J., Lerner, C. P., Richtsmeier, J. T., Leszl, J. M., Hill, C. A., Yu, K., Ornitz, D. M., Elisseeff, J., Huso, D. L., Jabs, E. W. (2005). Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse. Development 132: 3537-3548 [Abstract] [Full Text]  
• Yu, H.-M. I., Liu, B., Chiu, S.-Y., Costantini, F., Hsu, W. (2005). Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. Proc. Natl. Acad. Sci. USA 102: 8615-8620 [Abstract] [Full Text]  
• Guenou, H., Kaabeche, K., Mee, S. L., Marie, P. J. (2005). A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. Hum Mol Genet 14: 1429-1439 [Abstract] [Full Text]  
• Yu, H.-M. I., Jerchow, B., Sheu, T.-J., Liu, B., Costantini, F., Puzas, J. E., Birchmeier, W., Hsu, W. (2005). The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132: 1995-2005 [Abstract] [Full Text]  
• Mansukhani, A., Ambrosetti, D., Holmes, G., Cornivelli, L., Basilico, C. (2005). Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. JCB 168: 1065-1076 [Abstract] [Full Text]  
• Kaabeche, K., Guenou, H., Bouvard, D., Didelot, N., Listrat, A., Marie, P. J. (2005). Cbl-mediated ubiquitination of {alpha}5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. J. Cell Sci. 118: 1223-1232 [Abstract] [Full Text]  
• Tanimoto, Y., Yokozeki, M., Hiura, K., Matsumoto, K., Nakanishi, H., Matsumoto, T., Marie, P. J., Moriyama, K. (2004). A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome. J. Biol. Chem. 279: 45926-45934 [Abstract] [Full Text]  
• Kaabeche, K., Lemonnier, J., Le Mee, S., Caverzasio, J., Marie, P. J. (2004). Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation. J. Biol. Chem. 279: 36259-36267 [Abstract] [Full Text]  
• Eswarakumar, V. P., Horowitz, M. C., Locklin, R., Morriss-Kay, G. M., Lonai, P. (2004). A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA 101: 12555-12560 [Abstract] [Full Text]  
• Valverde-Franco, G., Liu, H., Davidson, D., Chai, S., Valderrama-Carvajal, H., Goltzman, D., Ornitz, D. M., Henderson, J. E. (2004). Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum Mol Genet 13: 271-284 [Abstract] [Full Text]  
• Raucci, A., Laplantine, E., Mansukhani, A., Basilico, C. (2004). Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of Chondrocytes. J. Biol. Chem. 279: 1747-1756 [Abstract] [Full Text]  
• Liu, A., Li, J. Y. H., Bromleigh, C., Lao, Z., Niswander, L. A., Joyner, A. L. (2003). FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors. Development 130: 6175-6185 [Abstract] [Full Text]  
• Cowan, C. M., Quarto, N., Warren, S. M., Salim, A., Longaker, M. T. (2003). Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis. J. Biol. Chem. 278: 32005-32013 [Abstract] [Full Text]  
• Dailey, L., Laplantine, E., Priore, R., Basilico, C. (2003). A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. JCB 161: 1053-1066 [Abstract] [Full Text]  
• Laplantine, E., Rossi, F., Sahni, M., Basilico, C., Cobrinik, D. (2002). FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. JCB 158: 741-750 [Abstract] [Full Text]  
• Ornitz, D. M., Marie, P. J. (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16: 1446-1465 [Full Text]  
• Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C.-Y., McCauley, L. K. (2002). Parathyroid Hormone and Parathyroid Hormone-related Protein Exert Both Pro- and Anti-apoptotic Effects in Mesenchymal Cells. J. Biol. Chem. 277: 19374-19381 [Abstract] [Full Text]  
• Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N., Takada, S. (2002). FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16: 870-879 [Abstract] [Full Text]  
• Kearns, A. E., Donohue, M. M., Sanyal, B., Demay, M. B. (2001). Cloning and Characterization of a Novel Protein Kinase That Impairs Osteoblast Differentiation in Vitro. J. Biol. Chem. 276: 42213-42218 [Abstract] [Full Text]  
• Amsterdam, A., Kannan, K., Givol, D., Yoshida, Y., Tajima, K., Dantes, A. (2001). Apoptosis of Granulosa Cells and Female Infertility in Achondroplastic Mice Expressing Mutant Fibroblast Growth Factor Receptor 3G374R. Mol. Endocrinol. 15: 1610-1623 [Abstract] [Full Text]  
• Yang, J., Fizazi, K., Peleg, S., Sikes, C. R., Raymond, A. K., Jamal, N., Hu, M., Olive, M., Martinez, L. A., Wood, C. G., Logothetis, C. J., Karsenty, G., Navone, N. M. (2001). Prostate Cancer Cells Induce Osteoblast Differentiation through a Cbfa1-dependent Pathway. Cancer Res. 61: 5652-5659 [Abstract] [Full Text]  
• Sahni, M., Raz, R., Coffin, J. D., Levy, D., Basilico, C. (2001). STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128: 2119-2129 [Abstract] [Full Text]  
• Ibrahimi, O. A., Eliseenkova, A. V., Plotnikov, A. N., Yu, K., Ornitz, D. M., Mohammadi, M. (2001). Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 10.1073/pnas.121183798v1 [Abstract] [Full Text]  
• Lemonnier, J., Hay, E., Delannoy, P., Fromigue, O., Lomri, A., Modrowski, D., Marie, P. J. (2001). Increased Osteoblast Apoptosis in Apert Craniosynostosis : Role of Protein Kinase C and Interleukin-1. Am. J. Pathol. 158: 1833-1842 [Abstract] [Full Text]  
• Van den Berghe, L., Laurell, H., Huez, I., Zanibellato, C., Prats, H., Bugler, B. (2000). FIF [Fibroblast Growth Factor-2 (FGF-2)-Interacting-Factor], a Nuclear Putatively Antiapoptotic Factor, Interacts Specifically with FGF-2. Mol. Endocrinol. 14: 1709-1724 [Abstract] [Full Text]  
• Hay, E., Lemonnier, J., Fromigue, O., Marie, P. J. (2001). Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway. J. Biol. Chem. 276: 29028-29036 [Abstract] [Full Text]  
• Ibrahimi, O. A., Eliseenkova, A. V., Plotnikov, A. N., Yu, K., Ornitz, D. M., Mohammadi, M. (2001). Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 98: 7182-7187 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents